Impact of SARS-CoV-2 immunization on a breast screening programme
e202208054
Keywords:
Screening, Breast cancer, Immunization, Vaccination, SARS-CoV-2, Coronavirus, MammogramAbstract
ipsilateral to the vaccinated site. Eventually, an increased in size of the axillary lymph nodes may lead to a misinterpretation of the breast screening mammogram, performed in asymptomatic women between the age 50 to 69 years old for early breast cancer diagnosis. The aim of our research was to evaluate the impact of the vaccination for SARS-CoV-2 in the breast screening programmes in terms of recall rates and number of false positive results. As a secondary purpose we would analysed the protocols adopted by different breast screening units around the world after SARS-CoV-2 vaccination.
METHODS // Observational and retrospective study analysing breast screening mammograms from a single Breast Cancer Screening Unit in Madrid. The mammograms of previously vaccinated women were analysed, reviewing the axillary lymph nodes and the re-call rate secondary to axillary lymphadenopathies.
RESULTS // Four hundred and twenty three screening mammograms were performed in May 2021 in the University Hospital Ramon y Cajal in Madrid, which is part of the Breast Screening Programme in Madrid, Spain. None of the women previously vaccinated for SARS-CoV-2 were recalled for complementary studies due to an increased in the axillary lymph nodes.
CONCLUSIONS // The protocol stablished by the Spanish Society of Breast Image that stands up for a routine breast screening mammogram after SARS-CoV-2 immunization, has no increase in the recall rate or increase in number of false positives.
Downloads
References
Brown A, Shah S, Dluzewski S et al. Unilateral axillary adenopathy following COVID-19 vaccination: a multimodality pictorial illustration and review of current guidelines. Radiology; 2021 (8): 553-558.
Alvarez M, Carreira C, Martínez M, Rodríguez A, Romero C. Recomendaciones de la SEDIM para el manejo de mujeres con antecedentes de vacunación para COVID-19 reciente. Disponible en: SEDIM Sociedad Española de Diagnóstico por Imagen de la Mama | Sociedad Española de Diagnóstico por Imagen de la Mama SEDIM (https://www.sedim.es).
Lim ET et al. Pathological axillary lymph nodes detected at mammographic screening. Clin Radiol. 2004; 59 (1): 86-91.
Local reactions, systemic reactions, adverse events and serious adverse events: Moderna COVID-19 Vaccine. Centers for Disease control and prevention. January 16, 2021.
Local reactions, systemic reactions, adverse events and serious adverse events: Pfizer-BioNTech COVID-19 Vaccine. Centers for Disease control and prevention. January 16, 2021.
Mehta N, Sales R, Babagbemi K et al. Unilateral axillary adenopathy in the setting of COVID-19 vaccines. Clin Imaging 2021; 75:12-15.
Grimm L et al. SBI care and delivery committee. SBI recommendations for management of axillary adenopathy in patients with recent COVID 19 vaccination. Disponible en: https://www.oregon.gov/oha/PH/HEALTHYPEOPLEFAMILIES/WOMEN/HEALTHSCREENING/Documents/sbi-recommendations.pdf
PEE. Advice for women following COVID.19 vaccination. Disponible en: National email message template-February 2020. Disponible en: https://www.england.nhs.uk/south/wp-content/uploads/sites/6/2021/03/20210308_CascadeCovidVaccine-v01.00-002.pdf
Sickles E, Orsi CD, LW B et al. BI RADS: Mammography. Breast Imaging Reporting and Data System: ACR BI RADS-Breast Imaging Atlas. 5th ed. Reston, VA: American College of Radiology, 201.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Teresa Presa Abós, Irene Vicente Zapata, Miguel Chiva De Agustín
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
